Choksi Laboratories Ltd
NSE: BSE: 526546
₹110.95
(0.86%)
Sat, 07 Mar 2026, 01:22 am
Market Cap772.8M
PE Ratio41.57
Dividend0
Commercial Services
Miscellaneous Commercial Services
24.5KChoksi Laboratories Analysis
dividend
- Unable to evaluate Choksi Laboratories's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Choksi Laboratories's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Choksi Laboratories is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Choksi Laboratories has been profitable on average in the past, therefore cash runway is not a concern.
- Choksi Laboratories has been profitable on average in the past, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (30.8%, greater than 20% of total debt).
- Debt is not covered by short term assets, assets are 0.7x debt.
- Choksi Laboratories's long term commitments exceed its cash and other short term assets.
- The level of debt compared to net worth has increased over the past 5 years (44% vs 97.7% today).
- Choksi Laboratories is making a loss, therefore interest payments are not well covered by earnings.
- Choksi Laboratories's level of debt (97.7%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
- The average tenure for the Choksi Laboratories board of directors is over 10 years, this suggests they are a seasoned and experienced board.
- Sunil's remuneration is about average for companies of similar size in India.
- Sunil's compensation has increased whilst company is loss making.
misc
- Choksi Laboratories is not covered by any analysts.
past
- Unable to compare Choksi Laboratories's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Choksi Laboratories does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
- Choksi Laboratories used its assets less efficiently than the IN Professional Services industry average last year based on Return on Assets.
- It is difficult to establish if Choksi Laboratories improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- It is difficult to establish if Choksi Laboratories has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- Unable to compare Choksi Laboratories's 1-year growth to the IN Professional Services industry average as it is not currently profitable.
value
- Choksi Laboratories is good value based on assets compared to the IN Professional Services industry average.
- 526546 outperformed the Professional Services industry which returned -30.2% over the past year.
- Choksi Laboratories's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Choksi Laboratories's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Choksi Laboratories is loss making, we can't compare its value to the IN Professional Services industry average.
- Choksi Laboratories is loss making, we can't compare the value of its earnings to the India market.
- 526546 underperformed the Market in India which returned -14.5% over the past year.
- BSE:526546 is down -1.1% underperforming the Professional Services industry which returned 20.3% over the past month.
- BSE:526546 is down -1.1% underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800